The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
New Guidance for Managing HCV-Related Cryoglobulinemic Vasculitis
September 16th 2013New reports in 3 major journals describe the prevalence of hepatitis C, outcomes of life-threatening related cryglobulinemic vasculitis, and an algorithm for managing the vasculitis. Also in the non-rheumatology journals: Targeting IL-17 in ankylosing spondylitis and other rheumatologic conditions.
European Drugs Agency Approves Biosimilar Form of Infliximab
September 14th 2013For the first time, the European Medicines Agency's biosimilars program has recommended approval of a monoclonal antibody. It has given thumbs-up to an alternative formulation of infliximab to treat inflammatory conditions including RA, ankylosing spondylitis, and psoriatic arthritis.
Benefits of Golimumab Plus MTX in RA Sustained at 1 Year
September 12th 2013Intravenous golimumab plus methotrexate produces sustained apparent clinical benefits and inhibits radiographic progression with few adverse events in patients with active RA, according to 1-year results from a multinational phase III trial.
Bisphosphonates Generally Ineffective in Treating Osteoarthritis Pain
September 11th 2013Review of the literature finds that although zoledronate and alendronate may have some potential for effective pain management in patients with knee and hip osteoarthritis, overall there is limited evidence supporting the use of bisphosphonates to treat OA pain.
Opioid Therapy the Only Treatment Option Left Standing in Chronic Pain Debate
Although clinical psychiatrist Michael E. Schatman, PhD, CPE, formerly "beat the hell out of the opioid industry," he spent an hour on the PAINWeek stage supporting his new belief that "maybe it's time to stop fighting."
Etanercept-MTX Combo Slightly Better in RA Than Etanercept Alone
September 5th 2013Rheumatoid arthritis patients taking a combination of etanercept (Enbrel) and methotrexate do better, but only slightly, than those on monotherapy with the tumor necrosis factor-α inhibitor, according to a Canadian multicenter clinical trial.
Autoimmune Rheumatology in Brief: Lancet Reviews and Forecasts
September 4th 2013Last week the major British journal published an exhaustive series of reviews on autoimmune rheumatic disease, summarized briefly here. Also new in the nonspecialty journals: Macitentan for pulmonary hypertension, small fiber neuropathy in Sjögren syndrome, and risk factors for infection with glucocorticoids.
Depression and Autoimmunity: The Biological Connection
August 21st 2013(AUDIO) Depression that complicates chronic inflammatory illness is not just a reaction to the symptoms, says internist/psychiatrist Andrew Cutler. Mediators of inflammation alter neurotransmitters, allowing new approaches that treat both conditions.